Lv3
340 积分 2025-02-14 加入
The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Rα-armored CAR-T cells against glioblastoma
24天前
已完结
Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR-T Cells Against Hematological Malignancies
1个月前
已完结
CD106 in tumor-specific exhausted CD8+ T cells mediates immunosuppression by inhibiting TCR signaling
2个月前
已完结
CAR-T therapy in solid tumors
3个月前
已完结
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
3个月前
已完结
皖公网安备34019202002308
